Related Experiment Video
Updated: May 11, 2026

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.9K
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma
Jennifer R Cracchiolo1, Fergal Kavanagh1, Michael T Starc2
1Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Oral Oncology
|February 17, 2026
Summary
A new classification system standardizes surgical documentation for sinonasal squamous cell carcinoma (SCC) treated with neoadjuvant therapy. This framework aids in evaluating response-adapted surgery for improved oncologic and functional outcomes.
Area of Science:
- Head and Neck Oncology
- Surgical Oncology
- Cancer Research
Background:
- Neoadjuvant systemic therapy and response-adapted surgery show promise for head and neck cancer.
- Standardized documentation is crucial for evaluating this approach in sinonasal tumors.
- A classification system for sinonasal tumor surgery is currently lacking.
Purpose of the Study:
- To develop a framework for documenting surgical extent and morbidity in sinonasal squamous cell carcinoma (SCC) following neoadjuvant therapy.
- To address the need for a system that accounts for the complex anatomy of sinonasal tumors.
- To facilitate the evaluation of response-adapted surgery in this patient population.
Main Methods:
- Literature review identified a gap in response-adapted surgery research for sinonasal malignancies.
- Development of a novel classification system based on surgical anatomy.
- Creation of a surgical morbidity score through a multidisciplinary expert consensus process.
Main Results:
- A novel classification system was developed to document sinonasal SCC resection before and after neoadjuvant treatment.
- The framework categorizes surgical adaptations by structures resected, exposure, reconstruction, and lymph node management.
- The classification system was endorsed by an institutional tumor board, establishing it as a standardized documentation tool.
Conclusions:
- The proposed system is the first response-adapted surgery classification for locoregionally advanced sinonasal SCC treated with neoadjuvant therapy.
- Standardized terminology improves multidisciplinary communication and enables cross-study comparisons.
- This framework supports consistent development of clinical trial endpoints balancing oncologic control and functional preservation.

